1991–92 Atlanta Hawks season

TendoNova Inks Partnership with AcCELLerated Biologics

Retrieved on: 
Wednesday, March 8, 2023
Tennis elbow, Injury, Pain, Atlanta Hawks, Tendinopathy, Physician, Tendon, Growth, Athlete, 1991–92 Atlanta Hawks season, Partnership, Debridement, Emory, Pharmaceutical industry, Ocelot

“The TendoNova Ocelot represents a great opportunity for improving the lives of over 30 million Americans affected by tendon pain,” said TendoNova CEO Mark A. Samuels.

Key Points: 
  • “The TendoNova Ocelot represents a great opportunity for improving the lives of over 30 million Americans affected by tendon pain,” said TendoNova CEO Mark A. Samuels.
  • “Our partnership with AcCELLerated Biologics will enable access to customers for their biologic products that are utilized adjacent to our Ocelot.”
    “For the past decade, AcCELLerated Biologics has been at the forefront of training and equipping physicians with new biologic tools useful in the treatment of a variety of injuries,” said AcCELLerated Biologics CEO Steve Whyte.
  • “Working with TendoNova allows us to expand our offering to help improve the surgical treatment that could be combined with biologics to produce positive outcomes.
  • TendoNova completed its manufacturing ramp-up in December 2022 and presently manufactures the Ocelot in Atlanta.